5:03 PM May 18, 2018

Shifting parts

HHS Secretary Alex Azar is convinced that the way Medicare Part B spends money for drugs makes no sense, costs the taxpayers too much and isn’t good for patients. He says he’s open to...

2:15 PM May 18, 2018

China comes to Europe

The historically underfunded European biotech sector is in the early stages of tapping into a new stream of capital thanks to the explosion of biomedical innovation in China, which has spawned a...

12:34 PM May 17, 2018

Europe’s piece of the pie

With China’s rising infrastructure for life science innovation and the unabated growth of U.S. science, Europe has two cards to play that can help it compete globally: expertise in key core...

5:25 PM May 11, 2018

Getting reorganized

FDA is reorganizing the Office of New Drugs in its Center for Drug Evaluation and Research, seeking to make review oversight more consistent while encouraging senior staff to become thought leaders.

3:55 PM May 11, 2018

Takeda hits the gas

Takeda Pharmaceutical Co. Ltd.’s proposed acquisition of Shire plc is an acceleration of -- not a departure from -- CEO Christophe Weber’s stated strategy to build a top-tier global pharma,...

1
2
3
4
5

Latest News

9:18 PM May 23, 2018

Scholar Rock raises $75M in IPO

Scholar Rock Holding Corp. (NASDAQ:SRRK) raised $75 million through the sale of 5.4 million shares at $14...

9:13 PM May 23, 2018

Kiniksa upsizes IPO, raises $152.6M

Kiniksa Pharmaceuticals Ltd. (NASDAQ:KNSA) raised $152.6 million through the sale of 8.5 million shares...

4:14 PM May 23, 2018

Aptinyx proposes $80M IPO

Neurology company Aptinyx Inc. (Evanston, Ill.) proposed to raise $80 million in an IPO on NASDAQ...

4:09 PM May 23, 2018

Management Tracks: Lilly, LogicBio

Eli Lilly and Co. (NYSE:LLY) said Lilly SVP and Lilly Oncology President Sue Mahony will retire at the end...

3:45 PM May 23, 2018

Clementia falls on Phase II data for rare bone disease

Clementia Pharmaceuticals Inc. (NASDAQ:CMTA) lost $4.05 (21%) to $14.85 on Wednesday after reporting data...

3:34 PM May 23, 2018

Takeda divests stake in Chinese JV

Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) spokesperson Vince Docherty told BioCentury on Wednesday that...

2:45 PM May 23, 2018

Gene, cell therapy fund-raising set to outpace 2017 total

Gene and cell therapy companies have raised $2.3 billion in equity in 2018 as of the end of last week,...

2:30 PM May 23, 2018

Vifor Fresenius to commercialize Cara’s Korsuva in international markets

Cara Therapeutics Inc. (NASDAQ:CARA) gained $4.96 (43%) to $16.56 on Wednesday after Vifor Fresenius...

2:16 PM May 23, 2018

Kronos raises seed round, names Bischofberger CEO

Cancer company Kronos Bio Inc. (Cambridge, Mass.) raised $18 million in seed financing Wednesday and hired...

12:55 PM May 23, 2018

Pfizer Ventures leads Strata's $26M series B

Strata Oncology Inc. (Ann Arbor, Mich.) raised $26 million in a series B round led by Pfizer Ventures....

12:55 PM May 23, 2018

Coherus raises $75M in follow-on

Coherus BioSciences Inc. (NASDAQ:CHRS) raised $75 million through the sale of 5.2 million shares at $14.50...

12:41 PM May 23, 2018

Senate readies smaller FDA budget boost

A Senate appropriations committee Tuesday approved a bill that would increase FDA's FY19 budget to $3...

11:33 AM May 23, 2018

Keytruda improves survival in first-line squamous NSCLC

Merck & Co. Inc. (NYSE:MRK) said Keytruda pembrolizumab plus chemotherapy met the primary endpoints of...

9:48 AM May 23, 2018

MyoKardia prices $184M follow-on

MyoKardia Inc. (NASDAQ:MYOK) raised $183.8 million late Tuesday through the sale of 3.8 million shares at $...

2:12 AM May 23, 2018

Lava raises €16M for gamma delta T cell platform

Lava Therapeutics B.V. ('s-Hertogenbosch, the Netherlands) raised €16 million ($18.8 million) in a...

4:05 PM May 22, 2018

Astellas unveils new R&D strategy

Astellas Pharma Inc. (Tokyo:4503) President and CEO Kenji Yasukawa, who took the reins in April, unveiled...

3:56 PM May 22, 2018

Trinity identifies hurdles for tissue-agnostic therapies

While the use of basket trials to test therapies in tissue agnostic, biomarker-based cancer indications is...

3:48 PM May 22, 2018

U.K., Gates Foundation giving $52M to CARB-X

The U.K. government and the Bill & Melinda Gates Foundation will contribute up to £20 million ($26.9...

3:45 PM May 22, 2018

FDA panel rebuffs Insys' analgesic

An FDA panel voted 18-1 that the benefits of Buvaya buprenorphine sublingual spray from Insys Therapeutics...

2:59 PM May 22, 2018

Management tracks: Trevena, Galecto

Neurology company Trevena Inc. (NASDAQ:TRVN) hired Mark Demitrack as SVP and CMO. He was VP of clinical...

Down Up